An interventional study of Mail-in Urine Test for EDCs in Endocrine Disrupting Chemicals, Environmental Exposure and Health Literacy, sponsored by Million Marker Wellness, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-14.
Sponsored by Million Marker Wellness, Inc. · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 79 studies in Literacy with a site in United States — 19 open to participants now, 22 under way, none of them phase 3. Literacy · United States.
Among the 79 studies in Literacy with a site in United States, this one is the 7th largest by enrollment of the 74 interventional ones that give a count, is one of 7 that started in 2022, is one of 70 with no phase, and was the 56th registered.
203 studies on the registry are indexed under Literacy; 69 are open to participants now.
Browse Literacy studies →19 of the 79 studies in Literacy with a site in United States are open now. Recruiting first, the newest first:
University of Miami · Sites in United States
Ages 6+ · Healthy volunteers
Hospital for Special Surgery, New York · Sites in United States
Ages 18+ · Healthy volunteers
Ohio State University · Sites in United States
Ages 42 mo–57 mo · Healthy volunteers
Brittany Willer · Sites in United States
Ages 3–17
Jackson State University · Sites in United States
Ages 18–45 · Women only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 29 Literacy studies recruiting now, 9 (31%) set no upper age limit and 17 (59%) stop at 75 or younger; 15 take children under 18; 19 take healthy volunteers.
This study: 18 Years to 40 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
79 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 2
First in 2002; this study’s year is marked. 7 started in 2022.
This study's enrollment of 434 is above the median of 124 across 172 interventional studies indexed under Literacy.
Median enrollment 105 across the 74 interventional studies, 150 across the 5 observational. Of the 54 that completed or were terminated, 13 (24%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 79 have an industry lead sponsor. The 10 most frequent:
Million Marker Wellness, Inc. is the lead sponsor of 6 studies on the registry; 1 is open to participants now.
Million Marker Wellness, Inc. has 1 study filed under Literacy — fewer than ten, so there is no comparison to draw.
3 of the studies in Literacy with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05760573Rutgers, The State University of New JerseyThe Ready and Healthy for Kindergarten Study | 2026-11-30 |
| NCT06456762Vanderbilt University Medical CenterText-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency | 2026-12-31 |
| NCT07505719Hospital for Special Surgery, New YorkComparing Original Patient Educational Materials vs. AI-Simplified Materials to Improve Patient Comprehension and Health Literacy | 2027-05 |
Add all 3 to your calendar (.ics) → With an account.
Among the 79 studies in Literacy with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this intervention study is to determine to what extent the Million Marker (MM) program reduces users' endocrine disruption chemical (EDC) exposure levels and changes their environmental health awareness and behaviors. The main questions it aims to answer are:
Exposures to endocrine disrupting chemicals (EDCs) have been linked to chronic diseases and conditions including breast cancer, metabolic syndrome, diabetes, and infertility. Timing of exposure, especially during pregnancy, may have a lifelong impact on the fetus, including neurodevelopmental problems and asthma. However, there have been no tools to allow those in the preconception, conception, and pregnancy stages to assess EDC exposures to ensure a healthy pregnancy and normal child development. Million Marker (MM) was born to fill this need. MM is a precision health company, built by a team of multidisciplinary scientists who are trained in environmental epidemiology, toxicology, analytical chemistry, biostatistics, data engineering, and business. MM's missions are to crowdsource and scale the biomonitoring of environmental chemicals and provide actionable results to consumers in a timely manner in order to empower individuals to proactively assess, track, and reduce their harmful environmental exposures. Starting with a few biomarkers of common EDCs, MM's ultimate vision is to discover all possible ("a million") biomarkers of harmful exposures to inform and improve individual health outcomes and advance precision medicine. Less than a year after it was founded, Million Marker developed and sold the first product-a mail-in urine test for BPA and phthalates-and successfully helped users reduce exposures through personalized intervention plans. Customers are able to order a test kit online, receive the test kit via mail, take a comprehensive exposure survey (via the Million Marker app), send back samples via mail, view personalized reports with tailored product recommendations through a secure online portal, make lifestyle changes to reduce exposures, and retest to monitor progress. MM's initial target audience are individuals of reproductive age, due to the vulnerability pregnancy and preconception to EDC exposures. However, it is unclear to what extent the MM platform educates, motivates, and ultimately reduces EDC exposure in individuals in this age range. Therefore, the aims of the current proposal are to 1) test and validate a this first-of-its-kind mobile EDC reduction program in a prospective longitudinal cohort intervention trial; 2) assess changes in participants' environmental health literacy, attitudes, knowledge, and behaviors after using MM's products and services; and 3) evaluate the MM app and platform usability to improve the user experience. Validating this population with MM's program is a step towards these types of future studies. At the conclusion of the project, MM will be well-positioned to begin Phase II and will scale the EDCs testing and personalized intervention plan to fertility clinics and the general public.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Million Marker's (MM) first-of-its-kind mobile endocrine disrupting chemical (EDC) reduction program will be tested and validated in a prospective longitudinal cohort intervention trial. 50 women in reproductive age and their partners will be recruited from the Healthy Nevada Project, an existing state-wide health monitoring effort. Using MM's services, participants' urine samples will be collected two times (at pre- and post-intervention) to measure changes in EDC levels. Changes in participants' environmental health literacy, attitudes, knowledge, and behaviors will be assessed after using MM's products and services. Validated surveys on environmental health literacy and readiness to change and analyses of participants' lifestyle behaviors and product use will be conducted at baseline (first test) and upon completion of the second test. The investigators will evaluate the MM app and platform usability to improve the user experience, using the System Usability Score (SUS) survey.
Diagnostic Test: Mail-in Urine Test for EDCs
Million Marker provides a mail-in urine test for Bisphenol A (BPA) and phthalates. Users take a comprehensive exposure survey (via the MM app), send back their samples, view their personalized reports with tailored product recommendations, make changes to reduce their exposures, and retest to monitor their progress. Participants will also fill out surveys to assess changes in their environmental health literacy, readiness to change, and analyses of lifestyle behaviors and product use.
Also known as: Million Marker Detect and Detox test kit
Changes in Endocrine Disrupting Chemical (EDC) Levels as Measured by the Post-intervention Value Minus the Baseline Value.
Urine samples collected pre- and post-intervention to measure changes in EDC levels
Time frame: Outcomes will be assessed at baseline (0-4 weeks) and up to 24 weeks for post-intervention
Changes in Environmental Health Literacy Using the Environmental Literacy Survey
Validated survey on environmental health literacy will be conducted at baseline and upon completion of the second test. The surveys will be compared for changes. The EHL survey was adapted from the "General Environmental Health Scale" and was titled "Environmental Health Literacy Scale" with three subscales: knowledge, attitudes, and behaviors. Knowledge and attitude responses ranged from strongly disagree (1) to strongly agree (5) and behavior responses ranged from never (1) to always (5). Scores were summed across 3 questions within each subscale resulting in a range of 3 (worse) to 15 (better) for each subscale.
Time frame: Outcomes will be assessed at baseline (0-4 weeks) and up to 24 weeks for post-intervention. Change scores are reported as the post-intervention subscale score minus the baseline score.
Between August 2021 and July 2022, recruitment emails describing the study and asking for participation were sent to Healthy Nevada Project participants.
| Milestone | Mobile EDC Reduction Program |
|---|---|
| Started | 434 |
| Completed | 50 |
| Not completed | 384 |
| Withdrew: Did not submit baseline urine test kit | 226 |
| Withdrew: Lost to follow-up | 34 |
| Withdrew: Did not submit second urine test kit | 124 |
Urine samples collected pre- and post-intervention to measure changes in EDC levels
| ng/ml | Mobile EDC Reduction Program |
|---|---|
| methylparaben | 5.83 ± 156.71 |
| propylparaben | 18.43 ± 105.85 |
| monobutyl phthalate | 56.94 ± 117.48 |
| monoethyl phthalate | 75.30 ± 556.90 |
| mono-(2-ethyl-5-carboxypentyl) phthalate | -3.47 ± 20.50 |
Validated survey on environmental health literacy will be conducted at baseline and upon completion of the second test. The surveys will be compared for changes. The EHL survey was adapted from the "General Environmental Health Scale" and was titled "Environmental Health Literacy Scale" with three subscales: knowledge, attitudes, and behaviors. Knowledge and attitude responses ranged from strongly disagree (1) to strongly agree (5) and behavior responses ranged from never (1) to always (5). Scores were summed across 3 questions within each subscale resulting in a range of 3 (worse) to 15 (better) for each subscale.
| units on a scale | Mobile EDC Reduction Program |
|---|---|
| EHL Knowledge subscale | -0.16 ± 1.13 |
| EHL attitudes subscale | -0.14 ± 1.54 |
| EHL behaviors subscale | 0.39 ± 1.70 |
Collected over The intervention, from time of the first survey and urinalysis to the last, was typically 8 weeks.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Mobile EDC Reduction Program | 0/434 (0%) | 0/434 (0%) | 0/434 (0%) |
| Age, Categorical(Participants) | Mobile EDC Reduction Program |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 434 |
| >=65 years | 0 |
| Age, Continuous(years) | Mobile EDC Reduction Program |
|---|---|
| Mean | 30.7 (18 to 40) |
| Sex: Female, Male(Participants) | Mobile EDC Reduction Program |
|---|---|
| Female | 328 |
| Male | 104 |
| Race/Ethnicity, Customized(Participants) | Mobile EDC Reduction Program |
|---|---|
| Asian | 12 |
| Black | 2 |
| Hispanic or Latino | 44 |
| Native American | 3 |
| Pacific Islander | 7 |
| White | 344 |
| Other | 22 |
| Region of Enrollment(participants) | Mobile EDC Reduction Program |
|---|---|
| United States | 434 |
| Baseline metabolite concentrations(ng/ml) | Mobile EDC Reduction Program |
|---|---|
| methyl paraben | 69.48 ± 215.69 |
| propyl paraben | 22.86 ± 87.07 |
| monobutyl phthalate | 71.52 ± 105.73 |
| monoethyl phthalate | 151.60 ± 442.17 |
| mono-(2-ethyl-5-carboxypentyl) phthalate | 5.32 ± 17.88 |
| Environmental Health Literacy(Scores on a Likert scale) | Mobile EDC Reduction Program |
|---|---|
| Knowledge subscale | 14.32 ± 0.85 |
| Attitudes subscale | 13.03 ± 1.54 |
| Behaviors subscale | 12.09 ± 2.03 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Million Marker will disseminate research results and findings to the scientific community through presentations at scientific meetings and conferences and publications in academic journals, as well as through the mass media and online postings. The Principal Investigator of this study will make data and associated documentation/metadata available to external researchers under a data-sharing agreement in which a specific commitment is made to use the data for research purposes only, to not provide the data to a third party or distribute it in any form, and to properly acknowledge the source of funding for the collection of the data and the researchers involved in this study.
Time frame: Starting 6 months after publication
Access criteria: Researchers must submit an acceptable research plan (goals of the proposed research, the specific hypotheses to be examined, justification for research and methods), be affiliated with a recognized research institution, have demonstrated expertise in the area of the proposed research project, and receive independent approval from their governing institutional review board. Data will be available for use only to answer the specific question(s) indicated in the research plan. The researchers must provide a list of variable names and an outline of how research findings will be disseminated; and will be asked to sign a data-sharing agreement that commits to: 1) not attempt to identify any individual participant, 2) secure the data using appropriate software technology, 3) and destroy or return all data once analyses are complete. All final datasets will be de-identified. Final authorship on manuscripts will require review and approval by the Principal Investigators of this study.
Ran from May 2022 to primary completion in Oct 2022, 5 months.
Results were first posted in May 2024, 1 year 6 months after primary completion.
Of 119 interventional studies with no phase under Literacy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 19. This study's 5 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Million Marker Wellness, Inc.